The discovery offers insight into why shift workers experience metabolic disruption, which could lead to new therapies for ...

Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...

Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement ...

Unlike the common cold—which, although miserable, usually doesn't hurt anyone—influenza can be serious business. Here's what ...

Adaptive Biotechnologies will host a conference call to discuss its third quarter 2024 financial results after market close on Thursday, November 7, 2024 at 4:30 PM Eastern Time. The conference call ...

If the study translates to humans, it points toward a new way of treating MS and other autoimmune disorders with supplements.

Interim phase 1 clinical trial update reveals the clinical potential of the tumor-activated IL-12 prodrug WTX-330, with favorable tolerability ...

GAITHERSBURG, Md., US, 06 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...

Celiac disease is a digestive and immune disorder that can keep the body from absorbing necessary nutrients. "Our conception and awareness of celiac disease has evolved over the past few decades, but ...

The topic of vaccines can be complex. It's important to know that not only have vaccines been around for centuries, but they ...

Checkpoint inhibitors are a novel breakthrough that unleash the immune system’s natural cancer-fighting abilities—mainly surveilling the body and eliminating any cancer cells it finds.

The term “immunity debt” is sometimes used to suggest that natural infections are better for our immune systems than vaccines and that pandemic-era restrictions were ineffective because people ...